01404nam a2200337Ia 4500001001500000003000900015005001700024006001900041007000700060008004100067020003200108040002300140090002400163092001700187100001700204245009900221260006200320300002600382490005000408504005100458505018100509530007400690538003600764650003200800650005300832655002800885776001800913830005100931856006700982999001701049CAH00CE7037PDFBD-DhSAU20151012144310.0m|||||o||d||||||||cr||||090127s2009    flua    sb    001 0 eng d  a9781420070392 (ebook : PDF)  aBD-DhSAUcBD-DhSAU  aRM301.27b.H47 2009  a615.19bH5721 aHerson, Jay.10aData and safety monitoring committees in clinical trialsh[electronic resource] /cJay Herson.  aBoca Raton :bChapman & Hall/CRC/Taylor & Francis,c2009.  axviii, 173 p. :bill.1 aChapman & Hall/CRC biostatistics series ;v30  aIncludes bibliographical references and index.0 aOrganization of a safety monitoring program -- Meetings -- Clinical issues -- Statistical issues -- Bias and pitfalls -- Data monitoring committee decisions -- Emerging issues.  aAlso available in print edition.bCRC Press (http://www.crcpress.com)  aMode of access: World Wide Web. 0aDrugsxTestingxEvaluation. 0aDrugsxTestingxStatistical methodsxEvaluation. 7aElectronic books.2lcsh1 z9781420070378 0aChapman & Hall/CRC biostatistics series ;v30.40uhttp://marc.crcnetbase.com/isbn/9781420070392qapplication/PDF  c12131d12130